The Hypertriglyceridemia Drug Pipeline Analysis explores emerging therapeutic developments aimed at managing elevated triglyceride levels, a key risk factor for cardiovascular diseases and pancreatitis. With rising global prevalence linked to obesity and diabetes, pharmaceutical companies are advancing novel therapies including omega-3 fatty acid derivatives, PPAR agonists, and antise... https://www.expertmarketresearch.com/clinical-trials/hypertriglyceridemia-drug-pipeline-insight